Search
Now showing items 1-1 of 1
Antibody-Redirected T-Cell Immunotherapy for Brain Tumors
(2014)
The most common primary malignant brain tumor, glioblastoma, is uniformly fatal.
Current therapy provides only incremental benefits in survival and is often incapacitating
owing to limits defined by nonspecific toxicity. ...